Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.

In an outbreak, effective detection of the aetiological agent(s) involved using molecular techniques is key to efficient diagnosis, early prevention and management of the spread. However, sequencing is necessary for mutation monitoring and tracking of clusters of transmission, development of diagnos...

Full description

Bibliographic Details
Main Authors: Joseph Ojonugwa Shaibu, Chika K Onwuamah, Ayorinde Babatunde James, Azuka Patrick Okwuraiwe, Olufemi Samuel Amoo, Olumuyiwa B Salu, Fehintola A Ige, Gideon Liboro, Ebenezer Odewale, Leona Chika Okoli, Rahaman A Ahmed, Dominic Achanya, Adesegun Adesesan, Oyewunmi Abosede Amuda, Judith Sokei, Bola A O Oyefolu, Babatunde Lawal Salako, Sunday Aremu Omilabu, Rosemary Ajuma Audu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0243271
id doaj-30ed2a12232f491da8851568e0dc0314
record_format Article
spelling doaj-30ed2a12232f491da8851568e0dc03142021-03-04T12:51:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024327110.1371/journal.pone.0243271Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.Joseph Ojonugwa ShaibuChika K OnwuamahAyorinde Babatunde JamesAzuka Patrick OkwuraiweOlufemi Samuel AmooOlumuyiwa B SaluFehintola A IgeGideon LiboroEbenezer OdewaleLeona Chika OkoliRahaman A AhmedDominic AchanyaAdesegun AdesesanOyewunmi Abosede AmudaJudith SokeiBola A O OyefoluBabatunde Lawal SalakoSunday Aremu OmilabuRosemary Ajuma AuduIn an outbreak, effective detection of the aetiological agent(s) involved using molecular techniques is key to efficient diagnosis, early prevention and management of the spread. However, sequencing is necessary for mutation monitoring and tracking of clusters of transmission, development of diagnostics and for vaccines and drug development. Many sequencing methods are fast evolving to reduce test turn-around-time and to increase through-put compared to Sanger sequencing method; however, Sanger sequencing remains the gold standard for clinical research sequencing with its 99.99% accuracy This study sought to generate sequence data of SARS-CoV-2 using Sanger sequencing method and to characterize them for possible site(s) of mutations. About 30 pairs of primers were designed, synthesized, and optimized using endpoint PCR to generate amplicons for the full length of the virus. Cycle sequencing using BigDye Terminator v.3.1 and capillary gel electrophoresis on ABI 3130xl genetic analyser were performed according to the manufacturers' instructions. The sequence data generated were assembled and analysed for variations using DNASTAR Lasergene 17 SeqMan Ultra. Total length of 29,760bp of SARS-CoV-2 was assembled from the sample analysed and deposited in GenBank with accession number: MT576584. Blast result of the sequence assembly shows a 99.97% identity with the reference sequence. Variations were noticed at positions: nt201, nt2997, nt14368, nt16535, nt20334, and nt28841-28843, which caused amino acid alterations at the S (aa614) and N (aa203-204) regions. The mutations observed at S and N-gene in this study may be indicative of a gradual changes in the genetic coding of the virus hence, the need for active surveillance of the viral genome.https://doi.org/10.1371/journal.pone.0243271
collection DOAJ
language English
format Article
sources DOAJ
author Joseph Ojonugwa Shaibu
Chika K Onwuamah
Ayorinde Babatunde James
Azuka Patrick Okwuraiwe
Olufemi Samuel Amoo
Olumuyiwa B Salu
Fehintola A Ige
Gideon Liboro
Ebenezer Odewale
Leona Chika Okoli
Rahaman A Ahmed
Dominic Achanya
Adesegun Adesesan
Oyewunmi Abosede Amuda
Judith Sokei
Bola A O Oyefolu
Babatunde Lawal Salako
Sunday Aremu Omilabu
Rosemary Ajuma Audu
spellingShingle Joseph Ojonugwa Shaibu
Chika K Onwuamah
Ayorinde Babatunde James
Azuka Patrick Okwuraiwe
Olufemi Samuel Amoo
Olumuyiwa B Salu
Fehintola A Ige
Gideon Liboro
Ebenezer Odewale
Leona Chika Okoli
Rahaman A Ahmed
Dominic Achanya
Adesegun Adesesan
Oyewunmi Abosede Amuda
Judith Sokei
Bola A O Oyefolu
Babatunde Lawal Salako
Sunday Aremu Omilabu
Rosemary Ajuma Audu
Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
PLoS ONE
author_facet Joseph Ojonugwa Shaibu
Chika K Onwuamah
Ayorinde Babatunde James
Azuka Patrick Okwuraiwe
Olufemi Samuel Amoo
Olumuyiwa B Salu
Fehintola A Ige
Gideon Liboro
Ebenezer Odewale
Leona Chika Okoli
Rahaman A Ahmed
Dominic Achanya
Adesegun Adesesan
Oyewunmi Abosede Amuda
Judith Sokei
Bola A O Oyefolu
Babatunde Lawal Salako
Sunday Aremu Omilabu
Rosemary Ajuma Audu
author_sort Joseph Ojonugwa Shaibu
title Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
title_short Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
title_full Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
title_fullStr Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
title_full_unstemmed Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
title_sort full length genomic sanger sequencing and phylogenetic analysis of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) in nigeria.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2021-01-01
description In an outbreak, effective detection of the aetiological agent(s) involved using molecular techniques is key to efficient diagnosis, early prevention and management of the spread. However, sequencing is necessary for mutation monitoring and tracking of clusters of transmission, development of diagnostics and for vaccines and drug development. Many sequencing methods are fast evolving to reduce test turn-around-time and to increase through-put compared to Sanger sequencing method; however, Sanger sequencing remains the gold standard for clinical research sequencing with its 99.99% accuracy This study sought to generate sequence data of SARS-CoV-2 using Sanger sequencing method and to characterize them for possible site(s) of mutations. About 30 pairs of primers were designed, synthesized, and optimized using endpoint PCR to generate amplicons for the full length of the virus. Cycle sequencing using BigDye Terminator v.3.1 and capillary gel electrophoresis on ABI 3130xl genetic analyser were performed according to the manufacturers' instructions. The sequence data generated were assembled and analysed for variations using DNASTAR Lasergene 17 SeqMan Ultra. Total length of 29,760bp of SARS-CoV-2 was assembled from the sample analysed and deposited in GenBank with accession number: MT576584. Blast result of the sequence assembly shows a 99.97% identity with the reference sequence. Variations were noticed at positions: nt201, nt2997, nt14368, nt16535, nt20334, and nt28841-28843, which caused amino acid alterations at the S (aa614) and N (aa203-204) regions. The mutations observed at S and N-gene in this study may be indicative of a gradual changes in the genetic coding of the virus hence, the need for active surveillance of the viral genome.
url https://doi.org/10.1371/journal.pone.0243271
work_keys_str_mv AT josephojonugwashaibu fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT chikakonwuamah fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT ayorindebabatundejames fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT azukapatrickokwuraiwe fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT olufemisamuelamoo fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT olumuyiwabsalu fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT fehintolaaige fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT gideonliboro fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT ebenezerodewale fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT leonachikaokoli fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT rahamanaahmed fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT dominicachanya fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT adesegunadesesan fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT oyewunmiabosedeamuda fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT judithsokei fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT bolaaooyefolu fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT babatundelawalsalako fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT sundayaremuomilabu fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
AT rosemaryajumaaudu fulllengthgenomicsangersequencingandphylogeneticanalysisofsevereacuterespiratorysyndromecoronavirus2sarscov2innigeria
_version_ 1714801177313411072